Put yourself in Teva's shoes. If in today's pr or if it has anything inside the FDA's letter that it could use to place the last nail into MNTA's coffin, it would. But it didn't, because it can't.
Still I have to say Teva is a formidable adversary and a very skilfull one at that.
Market Data 
Markets 
AI
